Clinical ResearchOne-Year Follow-Up of Feasibility and Safety of the First U.S., Randomized, Controlled Study Using 3-Dimensional Guided Catheter-Based Delivery of Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy (CAuSMIC Study)
Under an Elsevier user license
open archive
Key Words
catheter
heart failure
muscle cell
myocardial infarction
transplant
Abbreviations and Acronyms
AMT
autologous myoblast transplantation
CRT
cardiac resynchronization therapy
FDA
Food and Drug Administration
ICD
Implantable cardioverter-defibrillator
ILR
implantable loop recorder
MI
myocardial infarction
MLHFQ
Minnesota Living with Heart Failure Questionnaire
MMT
maximal medical therapy
NYHA
New York Heart Association
SAE
serious adverse event
SPECT
single-photon emission computed tomography
3D
three-dimensional
Cited by (0)
This study was sponsored by and funded by Mytogen, Inc., Charlestown, Massachusetts. Injection and mapping catheters were donated by Cordis/Biodelivery Systems, Inc., Diamond Bar, California.
Copyright © 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.